Skip to main content
. Author manuscript; available in PMC: 2013 Feb 13.
Published in final edited form as: J Clin Pharmacol. 2009 Oct 19;50(1):62–72. doi: 10.1177/0091270009337946

Table 1.

Patient demographics

Demographics Pittsburgh Patients Pisa Patients All patients
Number of Subjects 105 67 172
Number of Observations 320 153 473
Number of Observations for each subject 3.048 2.2836 2.75
CYP2C19 genotype
 Rapid metabolizers (RM, *17/*17) 4 1 5
 Extensive Metabolizers
 (EM, *17/*1,*1/*1)
54 23 77
 Intermediate Metabolizers
 (IM, *1/*2, *1/*3, *17/*2, *17/*3)
28 15 43
 Poor Metabolizers
 (PM, *2/*2, *3/*3, *2/*3)
3 0 3
 Missing 16 28 44
Age, Mean Years ± SD (range) 38.84 ± 12.05 (20.4-64.67) 40.58 ± 11.20 (21-65) 39.52 ± 11.73 (20.41 - 65)
Weight, mean kg ± SD (range) 81.6 ± 20 ( 31.9 - 139.7) 67.8 ± 15.2 (40-116) 76.25 ± 19.45 ( 31.9-139.7)
BMI, mean lbs/in2 ± SD (range) 28.20 ± 6.78 (15.55 - 48.26) 24.94 ± 4.52 (16.63-37.41) 26.93 ± 6.20 (15.55 - 48.26)
Sex, n (%)
 Male 47 (45) 7 (10) 54 (31)
 Female 58 (55) 60 (90) 118 (69)
Race, n (%)
 White 94 (89) 67 (100) 161 (93)
 Black/African American 8 (8) 0 (0) 8 (5)
 Asian 3 (3) 0 (0) 3 (2)